(Q42979897)

English

Treatment with recombinant interferon-alpha 2a for patients with chronic hepatitis C: predictive factors for biochemical and virologic response. Osaka Liver Disease Study Group

scientific article published on October 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Treatment with recombinant interferon-alpha 2a for patients with chronic hepatitis C: predictive factors for biochemical and virologic response. Osaka Liver Disease Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

0 references

chronic hepatitis C

1 reference

based on heuristic

inferred from title

author name string

H Hagiwara

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

N Hayashi

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

A Kasahara

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

M Oshita

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

K Katayama

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

M Kato

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

M Masuzawa

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

H Fusamoto

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

M Sakurai

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

T Kamada

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 October 1996

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Scandinavian Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1021-1026

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV).

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease

1 reference

https://api.crossref.org/works/10.3109%2F00365529609003123

21 January 2018

Identifiers

10.3109/00365529609003123

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42979897&oldid=1975622323"